AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 281 min read$TDOC

Teladoc: Q3 Earnings Snapshot

Teladoc Inc. (TDOC) reported a Q3 loss of $26.9M, or 15 cents per share, beating analyst expectations of a 23 cents per share loss. Revenue was $605.1M, exceeding forecasts of $585.5M. The company expects Q4 revenue between $569M and $615M, and full-year revenue between $2.4B and $2.44B, with a loss per share between 95 and 75 cents.

Original reporting
finance.yahoo.com
Published Oct 28, 2026, 8:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Teladoc: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$TDOCBullishHigh
01

Why it matters

The earnings surprise may trigger short covering and buying interest, especially from investors focused on digital health recovery.

02

Market read

First‑report earnings data for a mid‑cap telehealth firm, offering actionable insight for short‑term traders.

03

What to watch

Potential headwinds from payer reimbursement pressures and competition could temper upside.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Teladoc reported Q3 results that beat analyst expectations on both loss per share and revenue, and provided guidance for Q4 and full‑year performance.

Company-level read

Ticker impact

$TDOCBullishHigh confidence
Context

Q3 earnings beat expectations on both loss per share and revenue, with guidance for Q4 and full year provided.

Expected impact

likely upside as market prices in better-than-expected results and guidance

Evidence & confidence

The surprise loss beat and revenue beat reduce downside risk and suggest improved operating performance, prompting buying pressure.

Market effects

Sector

Telehealth sector may see modest uplift as Teladoc's beat suggests demand resilience.

Regional

U.S. market may see a small positive bias in health‑tech stocks.

Global

Limited to investors tracking U.S. digital health equities.

Counterpoint

What could challenge this read

Some investors may view the continued loss guidance as a red flag despite the beat.

Key entities

  • company
    Teladoc Inc.

    U.S. telehealth services provider.

Read at source← All news

StoryTeladoc reports narrower Q3 loss and raises full-year outlook

Also covered by

1 outlet

Related articles

OCT 28
$TDOCHighAI 8/10

Teladoc shares surge 9% on narrower-than-feared loss, raised outlook

Teladoc Health (TDOC) shares rose 9% after Q3 results beat expectations with a loss of -$0.15 per share vs. -$0.22 estimate, and revenue of $605.1M vs. $588.44M estimate. The company raised its full-year outlook, projecting a loss of -$0.75 to -$0.95 per share and revenue of $2.4B to $2.44B. Adjusted EBITDA increased 14% YoY to $79.4M, with the Integrated Care segment showing growth while BetterHelp declined 13% YoY.

investing.com2 min
OCT 28
$GOOGLHighAI 8/10

After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC

Alphabet (GOOGL) fell 8% after reporting Q3 revenue of $127.6B, missing EPS estimates. Microsoft (MSFT) rose 4% on strong cloud performance. ServiceNow (NOW) dropped 16% after an earnings miss. KLA (KLAC) gained 3% on strong guidance. Chipotle (CMG) rose 2% on revenue beat. Carvana (CVNA) climbed 6% on top-line beat. Teladoc (TDOC) gained 8% on smaller loss and revenue beat.

investing.com3 min
OCT 28
$TDOCHighAI 9/10

Teladoc (NYSE:TDOC) exceeds Q3 2026 expectations, stock jumps 11.5%

Teladoc (TDOC) reported Q3 2026 revenue of $605.1M, beating estimates by 2.8%, with EPS of -$0.15, a 30% beat. Adjusted EBITDA was $79.36M, a 16.6% beat. Q4 revenue guidance of $592M is slightly below estimates, while full-year EPS and EBITDA guidance beat expectations. Operating margin improved to -4.6% from -8.3% YoY, and free cash flow margin rose to 12.5% from 10.5% QoQ.

finance.yahoo.com2 min
OCT 28
$TDOCHighAI 8/10

Teladoc Health Reports Third Quarter 2026 Results

Teladoc Health, Inc. (TDOC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Teladoc Health Reports Third Quarter 2026 Results NEW YORK, October 28, 2026 — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third Quarter 2026”). Unless otherwis

SEC EDGAR 8-K2 min
SEP 28
$TDOCMed

Why is Teladoc stock sliding today?

Teladoc (TDOC) shares fell 2.3% to $5.95 amid leadership transition concerns. The company's CLO resigned, raising governance questions. The stock has declined since Q2 revenue missed expectations and guidance was cut. Analysts have lowered price targets, and institutional selling has increased. The broader market's decline added pressure. TDOC trades near its 52-week low of $4.40.

investing.com2 min